Stereotactic Ablative Radiotherapy as a Tool in Renal Cell Carcinoma for Building RAPPORT with Systemic Therapy

Affiliations

¹ Iridium Network, Radiation Oncology, Antwerp, Belgium; Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium. Electronic address: carole.mercier@gza.be.
² Department of Medical Oncology, GZA Sint-Augustinus, Antwerp, Belgium.
³ Iridium Network, Radiation Oncology, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.

Editorial

Carole Mercier et al. Eur Urol. 2022 Apr.

. 2022 Apr;81(4):373-374.

doi: 10.1016/j.eururo.2022.01.001. Epub 2022 Jan 19.

¹ Iridium Network, Radiation Oncology, Antwerp, Belgium; Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium. Electronic address: carole.mercier@gza.be.
² Department of Medical Oncology, GZA Sint-Augustinus, Antwerp, Belgium.
³ Iridium Network, Radiation Oncology, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.

No abstract available

Comment on

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial.
Siva S, Bressel M, Wood ST, Shaw MG, Loi S, Sandhu SK, Tran B, A Azad A, Lewin JH, Cuff KE, Liu HY, Moon D, Goad J, Wong LM, LimJoon M, Mooi J, Chander S, Murphy DG, Lawrentschuk N, Pryor D. Siva S, et al. Eur Urol. 2022 Apr;81(4):364-372. doi: 10.1016/j.eururo.2021.12.006. Epub 2021 Dec 23. Eur Urol. 2022. PMID: 34953600 Clinical Trial.